AI assistant
Oncopeptides Major Shareholding Notification 2021
3091_iss_2021-03-10_1b56c372-ab47-455e-bc70-bbdb00bd5310.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Oncopeptides AB
Holder
Fjärde AP-fonden
Instrument
| Instrument | Aktie | |||
|---|---|---|---|---|
| Before the transaction | ||||
| Shares | 3,271,310 | |||
| Voting rights | 3,271,310 | |||
| Transaction | ||||
| Date | 10/03/2021 | |||
| Limit for number of shares 5 % | ||||
| Limit for number of votes | 5 % |
After the transaction
Quantity
| Shares | 3,821,310 |
|---|---|
| Directly held voting rights 3,821,310 | |
| Indirectly held voting rights 0 |
Percentage
Directly held shares 5.09 % Directly held voting rights 5.09 % Indirectly held voting rights 0 %
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 5.09 % | 3,821,310 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, |
||
| first paragraph, line 3 - Physically settled |
||
| - Cash settled | ||
| Total | 5.09 % | 3,821,310 |
| Group total holdings |
||
| Voting rights 3,821,310 |
||
| Percentage of voting rights 5.09 | ||
| Published | ||
| 10/03/2021 20:20 | ||
| Contact | ||
| Name Jannis Kitsakis |
||
| Phone 070-6038023 Email [email protected] |
||
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25